Millennium Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$39.6M Buy
70,446
+66,976
+1,930% +$42.9M 0.02% 1007
2025
Q4
$2.35M Sell
3,470
-60,049
-95% -$40.9M ﹤0.01% 3795
2025
Q3
$40.6M Sell
63,519
-15,259
-19% -$9.26M 0.02% 1015
2025
Q2
$42.3M Buy
78,778
+39,270
+99% +$18.8M 0.02% 923
2025
Q1
$16.6M Sell
39,508
-216,720
-85% -$94.1M 0.01% 1710
2024
Q4
$106M Buy
256,228
+100,461
+64% +$44.1M 0.05% 373
2024
Q3
$78.7M Buy
155,767
+26,008
+20% +$12.6M 0.04% 560
2024
Q2
$63.2M Sell
129,759
-107,384
-45% -$53.9M 0.03% 657
2024
Q1
$128M Sell
237,143
-88,482
-27% -$48.4M 0.05% 351
2023
Q4
$181M Buy
325,625
+300,671
+1,205% +$141M 0.08% 204
2023
Q3
$10.9M Sell
24,954
-15,251
-38% -$7.61M 0.01% 1965
2023
Q2
$20.2M Sell
40,205
-239,944
-86% -$115M 0.01% 1379
2023
Q1
$140M Buy
280,149
+259,008
+1,225% +$124M 0.08% 207
2022
Q4
$8.63M Buy
21,141
+12,037
+132% +$4.67M ﹤0.01% 2293
2022
Q3
$2.97M Sell
9,104
-35,546
-80% -$13.1M ﹤0.01% 3402
2022
Q2
$15.7M Buy
44,650
+43,823
+5,299% +$17.9M 0.01% 1533
2022
Q1
$452K Sell
827
-26,304
-97% -$13.8M ﹤0.01% 5202
2021
Q4
$17.9M Sell
27,131
-5,404
-17% -$3.39M 0.01% 1546
2021
Q3
$20.2M Buy
32,535
+27,973
+613% +$18.8M 0.01% 1314
2021
Q2
$2.88M Sell
4,562
-91,512
-95% -$50.5M ﹤0.01% 3496
2021
Q1
$47M Buy
96,074
+65,623
+216% +$32.9M 0.03% 518
2020
Q4
$15.2M Sell
30,451
-20,393
-40% -$9.12M 0.01% 1302
2020
Q3
$20K Buy
50,844
+48,115
+1,763% +$17.8M 0.02% 803
2020
Q2
$901K Buy
+2,729
New +$790K ﹤0.01% 3055
2020
Q1
Sell
-25,662
Closed -$6.7M 4147
2019
Q4
$6.7M Buy
+25,662
New +$6.76M 0.01% 1688
2019
Q1
Sell
-23,089
Closed -$4.77M 4114
2018
Q4
$4.29M Sell
23,089
-101,917
-82% -$20.9M 0.01% 1688
2018
Q3
$31.2M Sell
125,006
-139,556
-53% -$33.9M 0.04% 619
2018
Q2
$57.7M Buy
264,562
+39,740
+18% +$8.19M 0.08% 346
2018
Q1
$43M Sell
224,822
-144,175
-39% -$26.6M 0.06% 489
2017
Q4
$57.7M Buy
368,997
+16,112
+5% +$2.54M 0.08% 347
2017
Q3
$54.9M Buy
352,885
+201,330
+133% +$31.8M 0.08% 315
2017
Q2
$24.5M Buy
151,555
+109,793
+263% +$17.8M 0.04% 581
2017
Q1
$6.46M Sell
41,762
-143,544
-77% -$19.8M 0.01% 1299
2016
Q4
$21.7M Buy
185,306
+14,304
+8% +$1.63M 0.05% 567
2016
Q3
$19.3M Buy
171,002
+150,407
+730% +$15.9M 0.03% 593
2016
Q2
$1.91M Sell
20,595
-66,064
-76% -$5.67M ﹤0.01% 1808
2016
Q1
$6.79M Buy
+86,659
New +$6.24M 0.02% 1069
2015
Q4
Sell
-87,412
Closed -$6.49M 3575
2015
Q3
$6.49M Buy
87,412
+20,832
+31% +$1.49M 0.01% 1186
2015
Q2
$4.27M Sell
66,580
-153,730
-70% -$10.6M 0.01% 1486
2015
Q1
$17M Sell
220,310
-203,880
-48% -$15.9M 0.03% 746
2014
Q4
$31.4M Buy
424,190
+148,594
+54% +$10.4M 0.07% 401
2014
Q3
$16.2M Buy
275,596
+215,446
+358% +$13.6M 0.04% 603
2014
Q2
$4.02M Buy
60,150
+32,872
+121% +$2.09M 0.01% 1347
2014
Q1
$1.66M Sell
27,278
-108,742
-80% -$6.48M ﹤0.01% 1924
2013
Q4
$7.23M Buy
+136,020
New +$7.16M 0.02% 915

Other funds holding IDXX

Millennium Management's IDXX Position: Q1 2026 in Review

Millennium Management increased its Idexx Laboratories (IDXX) stake by 1,930% in Q1 2026, buying an estimated $42.9M and bringing the position to 70,446 shares worth $39.6M. The position accounts for 0.02% of the portfolio, ranked #1007.

Millennium Management first reported a position in IDXX in Q4 2013 and has held it in 45 quarters since. The position peaked at $181M in Q4 2023. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Millennium Management held 70,446 shares of Idexx Laboratories worth $39.6M as of Q1 2026.
  • Millennium Management bought 66,976 Idexx Laboratories shares in Q1 2026, an estimated $42.9M.
  • Idexx Laboratories made up 0.02% of Millennium Management's portfolio in Q1 2026, its #1007 holding.
  • Millennium Management first reported a position in Idexx Laboratories in Q4 2013 and has held it in 45 quarters since.
  • Millennium Management's Idexx Laboratories position peaked at $181M in Q4 2023.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.